Solifenacin succinate, YM-53705(monoHCl), YM-905, Vesicare

琥珀酸索利那新 2(1H)-异喹啉羧酸,3,4-二氢-1-苯基,(3R)-1-氮环[2.2.2],酸盐-3-基酯,盐酸盐(1:1),(1R)- Chemical Name: 1(S)-Phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 3(R)-quinuclidinyl ester monosuccinate
CAS No. 242478-38-2, 180468-37-5 ([R-(R*,R*)]-isomer, monoHCl salt), 180468-38-6 ([S-(R*, R*)]-isomer, monoHCl salt), 180468-40-0 ([S-(R*, S*)]-isomer, monoHCl salt), 180468-39-7 (monoHCl), 180272-14-4 (undefined isomer, free base), 180272-16-6 (undefined isomer,
项目整合开发状态: Launched-2004
项目研究机构: Yamanouchi (Originator), GlaxoSmithKline (Comarketer)
合成路线:YM-905 has been obtained by two related ways:1) The benzoylation of 2-phenylethylamine (I) with benzoyl chloride (II) and triethylamine in chloroform,or with benzoic acid (III),DPPA and triethylamine in DMF,gives the corresponding benzamide (IV),which is cyclized by means of POCl3 and P2O5 in refluxing xylene and reduced with NaBH4 in ethanol,yielding racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V).The reaction of (V) with ethyl chloroformate by means of K2CO3 in chloroform affords racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI),which is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to provide the quinuclidinyl ester (VIII) as a diastereomeric mixture.This mixture is resolved by chiral HPLC,giving the target compound as a pure enantiomer.2) The racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V) can also be submitted to optical resolution with (+)-tartaric acid to give 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline (IX),which is condensed with ethyl chloroformate by means of K2CO3 in chloroform to afford 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI).This compound is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to directly provide the pure enantiomer.